1. Heighton JN, Brady LI, Newman MC, Tarnopolsky MA. Clinical and demographic features of chronic progressive external ophthalmoplegia in a large adult-onset cohort. Mitochondrion 2019;44:15–19.

2. Yu Wai Man CY, Smith T, Chinnery PF, Turnbull DM, Griffiths PG. Assessment of visual function in chronic progressive external ophthalmoplegia. Eye 2006;20:564–568.

3. Karimi N, Kashkouli MB, Tahanian F, Abdolalizadeh P, Jafarpour S, Ghahvehchian H. Long-term results of palpebral fissure transfer with no lower eyelid spacer in chronic progressive external ophthalmoplegia. Am J Ophthalmol 2022;234:99–107.

4. Wu Y, Kang L, Wu HL, Hou Y, Wang ZX. Optical coherence tomography findings in chronic progressive external ophthalmoplegia. Chin Med J 2019;132:1202– 1207.

5. Dehkordi FF, Houshmand M, Sadeghizadeh M, Kashkouli MB, Javadi G. Association of fibroblast growth factor (FGF- 21) as a screening biomarker for chronic progressive external ophthalmoplesia. Trop J Pharm Res 2014;13:377– 381.

6. Karimi N, Kashkouli MB. Reply to the letter “Long-Term Results of Palpebral Fissure Transfer With No Lower Eyelid Spacer in Chronic Progressive External Ophthalmoplegia”. Am J Ophthalmol 2022;236:320.

7. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320:1293–1299.

8. Quadir A, Pontifex CS, Lee Robertson H, Labos C, Pfeffer G. Systematic review and meta-analysis of cardiac involvement in mitochondrial myopathy. Neurol Genet 2019;5:e339.

9.Sabella-Jiménez V, Otero-Herrera C, Silvera-Redondo C, Garavito-Galofre P. Mitochondrial DNA deletion and duplication in Kearns-Sayre Syndrome (KSS) with initial presentation as Pearson Marrow-Pancreas Syndrome (PMPS): two case reports in Barranquilla, Colombia. Mol Genet Genomic Med 2020;8:e1509.

10. Rajput R, Sachdev A, Din N, Damato EM, Murray A. False positive acetylcholine receptor antibodies in a case of unilateral chronic progressive external ophthalmoplegia: Case report and review of literature. Orbit 2018;37:385– 388.

11. Vahdani K, McVeigh K, Harrison R, Williams M, Garrott H. Intracranial hypotension mimicking chronic progressive external ophthalmoplegia. Orbit 2018;37:371–374.

12. Bucelli RC, Lee MS, McClelland CM. Chronic progressive external ophthalmoplegia in the absence of ptosis. J Neuroophthalmol 2016;36:270–274.

13. Gonzalez-Moron D, Bueri J, Kauffman MA. Progressive external ophthalmoplegia (PEO) due to a mutation in the C10orf2 (PEO1) gene mimicking a myasthenic crisis. Case Rep 2013;2013:bcr2013010181.

14. Holloman CM, Wolfe LA, Gahl WA, Boerkoel CF. Kearns-Sayre syndrome presenting as isolated growth failure. Case Rep 2013;2013:bcr2012007272.

15. Ergül Y, Nişli K, Saygili A, Dindar A. Kearns-Sayre syndrome presenting as somatomedin C deficiency and complete heart block. Turk Kardiyol Dern Ars 2010;38:568–571.

16. Feddersen B, DE LA Fontaine L, Sass JO, Lutz J, Abicht A, Klopstock T, et al. Mitochondrial neurogastrointestinal encephalomyopathy mimicking anorexia nervosa. Am J Psychiatry 2009;166:494–495.

17. Gupta SN, Marks HG. Spinocerebellar ataxia type 7 mimicking Kearns-Sayre syndrome: A clinical diagnosis is desirable. J Neurol Sci 2008;264:173–176.

18. Behbehani R, Sharfuddin K, Anim JT. Mitochondrial ophthalmoplegia with fatigable weakness and elevated acetylcholine receptor antibody. J Neuroophthalmol 2007;27:41–44.

19. Ben Yaou R, Laforêt P, Bécane HM, et al. Errance diagnostique dans les myopathies mitochondriales: Étude de 12 patients thymectomisés [Misdiagnosis of mitochondrial myopathies: A study of 12 thymectomized patients]. Rev Neurol (Paris) 2006;162:339–346.

20. Fijołek J, Wiatr E, Wiechecka A, Torbicki A, Biederman A, Mickielewicz A, et al. [Pulmonary thromboembolism as a late complication of mitochondrial myopathy (Kearns- Sayer syndrome ]. Pneumonol Alergol Pol 2003;71:449– 457.

21. Corrado A, Cantatore FP, Serlenga L, Amati A, Petruzzella V, Lapadula G. Mitochondrial disease mimicking polymyositis: A case report. Clin Rheumatol 2002;21:411– 414.

22. van Domburg PH, Gabreëls-Festen AA, Gabreëls FJ, de Coo R, Ruitenbeek W, Wesseling P, et al. Mitochondrial cytopathy presenting as hereditary sensory neuropathy with progressive external ophthalmoplegia, ataxia and fatal myoclonic epileptic status. Brain 1996;119:997–1010.

23. Nørby S, Lestienne P, Nelson I, Nielsen IM, Schmalbruch H, Sjö O, et al. Juvenile Kearns-Sayre syndrome initially misdiagnosed as a psychosomatic disorder. J Med Genet 1994;31:45–50.

24. Krendel DA, Sanders DB, Massey JM. Single fiber electromyography in chronic progressive external ophthalmoplegia. Muscle Nerve 1987;10:299–302.

25. Gervasoni J, Primiano A, Marini F, Sabino A, Biancolillo A, Calvani R, et al. Fourier-transform infrared spectroscopy of skeletal muscle tissue: Expanding biomarkers in primary mitochondrial myopathies. Genes (Basel) 2020;11:1522.

26. Pfeffer G, Sirrs S, Wade NK, Mezei MM. Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Can J Neurol Sci 2011;38:119–123.

27. McClelland C, Manousakis G, Lee MS. Progressive external ophthalmoplegia. Curr Neurol Neurosci Rep 2016;16:53–53.

28. Giannoccaro MP, Paolucci M, Zenesini C, Di Stasi V, Donadio V, Avoni P, et al. Comparison of ice pack test and single-fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis. Neurology 2020;95:e1800–6.

29. Wong VA, Beckingsale PS, Oley CA, Sullivan TJ. Management of myogenic ptosis. Ophthalmology 2002;109:1023–1031.

30. Le Forestier N, Gherardi RK, Meyrignac C, Annane D, Marsac C, Gray F, et al. Myasthenic symptoms in patients with mitochondrial myopathies. Muscle Nerve 1995;18:1338–1340.

31. Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord 2006;16:459– 467.

32. Phadke R. Myopathology of adult and paediatric mitochondrial diseases. J Clin Med 2017;6:64.

33. Roefs AM, Waters PJ, Moore GR, Dolman PJ. Orbicularis oculi muscle biopsies for mitochondrial DNA analysis in suspected mitochondrial myopathy. Br J Ophthalmol 2012;96:1296–1299.